Investor Kingdon Capital Management, L.l.c.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Kingdon Capital Management, L.l.c. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-07-11 13G JSPR / Jasper Therapeutics, Inc. 765,000
2025-04-14 13G OPTN / OptiNose, Inc. 520,485
2024-11-13 13G/A CRIS / Curis, Inc. 345,730 90,000
2024-04-15 13G CRIS / Curis, Inc. 345,730
2024-02-06 13G/A AMNL / Applied Minerals, Inc. 30,906,049 21,265,377
2024-02-06 13G/A PRAX / Praxis Precision Medicines, Inc. 346,665
2023-11-29 13G/A SCYX / SCYNEXIS, Inc. 1,697,048 2,237,048
2023-04-13 13G SCYX / SCYNEXIS, Inc. 1,697,048
2023-02-06 13G/A AMNL / Applied Minerals, Inc. 20,969,195 30,906,049
2023-01-25 13G PRAX / Praxis Precision Medicines, Inc. 2,855,989
2022-02-10 13G/A AMNL / Applied Minerals, Inc. 20,565,027 20,969,195
2021-01-11 13G AMNL / Applied Minerals, Inc. 20,565,027 20,565,027
2021-01-11 13G AMNL / Applied Minerals, Inc. 19,373,489 20,565,027
2020-02-10 13G/A JAGX / Jaguar Health, Inc. 1,993,015 270
2020-02-10 13G/A GTYH / GTY Technology Holdings Inc 1,600,000 1,598,212
2020-02-10 13G/A SESN / Sesen Bio Inc. 5,239,557 4,040,835
2019-02-08 13G/A JAGX / Jaguar Health, Inc. 5,462,248 1,993,015
2019-02-04 13G GTYH / GTY Technology Holdings Inc 1,600,000
2019-02-04 13G/A SESN / Sesen Bio Inc. 5,239,557
2018-06-11 13D AMNL / Applied Minerals, Inc. 18,846,905 19,373,489
2018-04-04 13G SESN / Sesen Bio Inc. 2,213,980
2018-04-02 13G/A XAIR / Beyond Air, Inc. 400,859
2018-02-14 13G XAIR / Beyond Air, Inc. 500,001
2018-02-14 13G KKIC / KokiCare, Inc. 500,001
2018-02-14 13G/A FATE / Fate Therapeutics, Inc. 2,615,847 0
2018-02-14 13G/A HRTX / Heron Therapeutics, Inc. 3,848,161 2,179,620
2018-02-14 13G/A JAGX / Jaguar Health, Inc. 1,297,815 5,462,248
2018-02-14 13G/A HZNP / Horizon Therapeutics Plc 12,748,199 0
2018-02-14 13G/A 39036P100 / Great Elm Capital Group, Inc. 1,269,197 1,267,030
2018-01-02 13G/A AMNL / Applied Minerals, Inc. 18,587,783 18,846,905
2017-12-21 13G/A AMNL / Applied Minerals, Inc. 7,052,800 18,587,783
2017-02-17 13G/A AMNL / Applied Minerals, Inc. 5,572,882 7,052,800
2017-02-15 13G/A 39036P100 / Great Elm Capital Group, Inc. 1,269,197
2017-02-15 13G/A 39036P100 / Great Elm Capital Group, Inc. 1,269,197 1,269,197
2017-02-15 13G/A FATE / Fate Therapeutics, Inc. 2,596,489 2,615,847
2017-02-15 13G HZNP / Horizon Therapeutics Plc 4,776,229 12,748,199
2017-02-15 13G/A JAGX / Jaguar Health, Inc. 1,297,815 1,297,815
2017-02-15 13G/A AMNL / Applied Minerals, Inc. 5,572,882 5,572,882
2017-02-14 13G/A AMNL / Applied Minerals, Inc. 6,018,863 5,572,882
2017-02-14 13G/A 39036P100 / Great Elm Capital Group, Inc. 1,269,197
2017-02-14 13G/A JAGX / Jaguar Health, Inc. 734,746 1,297,815
2017-02-14 13G/A PLXP / PLx Pharma Inc. 975,099 0
2017-02-14 13G/A TNXP / Tonix Pharmaceuticals Holding Corp. 1,467,858 696,455
2017-02-14 13G HRTX / Heron Therapeutics, Inc. 1,669,029 3,848,161
2016-02-16 13G/A FLXN / Horizon Funds - Horizon Flexible Income ETF 769,903
2016-02-16 13G/A TNXP / Tonix Pharmaceuticals Holding Corp. 1,467,858
2016-02-16 13G/A FATE / Fate Therapeutics, Inc. 2,390,512 2,596,489
2016-02-16 13G/A HZNP / Horizon Therapeutics Plc 4,776,229
2016-02-16 13G/A PLXP / PLx Pharma Inc. 975,099
2016-02-16 13G/A JAGX / Jaguar Health, Inc. 726,576 734,746
2016-02-16 13G/A XOMA / XOMA Royalty Corporation 10,823,779 1,012,145
2016-02-16 13G/A HRTX / Heron Therapeutics, Inc. 2,833,791 1,669,029
2016-02-16 13G/A AMNL / Applied Minerals, Inc. 5,739,630 6,018,863
2016-02-16 13G/A VNDA / Vanda Pharmaceuticals Inc. 934,568 934,568
2015-12-23 13G JAGX / Jaguar Health, Inc. 726,576
2015-06-08 13G/A XOMA / XOMA Royalty Corporation 10,823,779
2015-06-08 13G HRTX / Heron Therapeutics, Inc. 2,833,791
2015-05-28 13G/A FATE / Fate Therapeutics, Inc. 2,390,512
2015-05-26 13G AMNL / Applied Minerals, Inc. 5,739,630
2015-02-17 13G TNXP / Tonix Pharmaceuticals Holding Corp. 575,000
2015-02-17 13G HZNP / Horizon Therapeutics Plc 6,374,616
2015-02-17 13G/A VNDA / Vanda Pharmaceuticals Inc. 2,461,305
2015-02-17 13G/A AEGR / Aegerion Pharmaceuticals, Inc. 0
2015-02-17 13G/A 032420101 / Anacor Pharmaceuticals, Inc. 1,180,306
2015-02-17 13G XOMA / XOMA Royalty Corporation 8,044,676
2015-02-17 13G FLXN / Horizon Funds - Horizon Flexible Income ETF 1,037,489
2015-02-17 13G FATE / Fate Therapeutics, Inc. 1,554,175
2015-02-17 13G/A 91531F103 / General Electric Capital Corp. 6.10#% Public Income Bonds PINES due 2032-11-15 6,540,246
2014-11-28 13G PLXP / PLx Pharma Inc. 730,000
2014-02-14 13G/A 91531F103 / General Electric Capital Corp. 6.10#% Public Income Bonds PINES due 2032-11-15 5,215,346
2014-02-14 13G AEGR / Aegerion Pharmaceuticals, Inc. 1,538,410
2014-02-14 13G VNDA / Vanda Pharmaceuticals Inc. 2,239,350
2014-02-14 13G/A 032420101 / Anacor Pharmaceuticals, Inc. 1,651,437
2013-07-16 13D 3,640,000
2013-02-20 13G 032420101 / Anacor Pharmaceuticals, Inc. 1,900,000
2013-02-14 13G/A 91531F103 / General Electric Capital Corp. 6.10#% Public Income Bonds PINES due 2032-11-15 4,553,476
2013-02-14 13G/A 3,640,000
2012-02-14 13G/A 39036P100 / Great Elm Capital Group, Inc. 4,900,001
2012-02-14 13G/A ACTG / Acacia Research Corporation 0
2012-02-14 13G/A OUTR / Outerwall Inc. 0
2012-01-26 13G 3,440,000